Sionna Therapeutics, Inc. Common Stock SION Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $65.56M+8.8% | $60.26M+1.5% | $59.35M-12.6% | $67.89M+11.8% | $60.74M+6.0% | ||
| $33.36M+16.2% | $28.72M+18.9% | $24.16M+22.0% | $19.8M+21.2% | $16.33M+23.1% | ||
| $98.92M+11.2% | $88.98M+6.6% | $83.5M-4.8% | $87.68M+13.8% | $77.07M+9.2% | ||
| -$98.92M-11.2% | -$88.98M-6.6% | -$83.5M+4.8% | -$87.68M-13.8% | -$77.07M-9.2% | ||
| $13.36M-2.6% | $13.71M+6.9% | $12.83M+8.3% | $11.84M+10.2% | $10.75M+21.2% | ||
| -$85.57M-13.7% | -$75.27M-6.5% | -$70.68M+6.8% | -$75.84M-14.3% | -$66.32M-7.5% | ||
| -$411.510.0% | -$411.53+0.7% | -$414.26+1.2% | -$419.47+84.6% | -$2,719.47+58.5% | ||
| -$98.42M-11.2% | -$88.47M-6.6% | -$82.98M+4.7% | -$87.06M-14.0% | -$76.34M-9.3% | ||
| -$98.92M-11.2% | -$88.98M-6.6% | -$83.5M+4.8% | -$87.68M-13.8% | -$77.07M-9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.